Global Contrast Media/Contrast Agents Sales Market (Sales,Revenue And Competitors Analysis Of Major Market) From 2014-2026
Table of Contents
1 Executive Summary
- 1.1 Definition and Specification
- 1.2 Report Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.2.3 Type Overview
- 1.2.4 Application Overview
- 1.3 Industrial Chain
- 1.3.1 Contrast Media/Contrast Agents Overall Industrial Chain
- 1.3.2 Upstream
- 1.3.3 Downstream
- 1.4 Industry Situation
- 1.4.1 Industrial Policy
- 1.4.2 Product Preference
- 1.4.3 Economic/Political Environment
- 1.5 SWOT Analysis
2 Market Analysis by Types
- 2.1 Overall Market Performance(Volume)
- 2.1.1 Iodinated
- 2.1.2 Gadolinium-Based
- 2.1.3 Barium-Based
- 2.2 Overall Market Performance(Value)
- 2.2.1 Iodinated
- 2.2.2 Gadolinium-Based
- 2.2.3 Barium-Based
3 Product Application Market
- 3.1 Overall Market Performance (Volume)
- 3.1.1 Cardiology
- 3.1.2 Oncology
- 3.1.3 Neurology
- 3.1.4 Others
4 Manufacturers Profiles/Analysis
- 4.1 Guerbet Group
- 4.1.1 Guerbet Group Profiles
- 4.1.2 Guerbet Group Product Information
- 4.1.3 Guerbet Group Contrast Media/Contrast Agents Sales, Sales Value(Million USD), Price and Gross Profit
- 4.1.4 Guerbet Group SWOT Analysis
- 4.2 Bayer Healthcare
- 4.2.1 Bayer Healthcare Profiles
- 4.2.2 Bayer Healthcare Product Information
- 4.2.3 Bayer Healthcare Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.2.4 Bayer Healthcare SWOT Analysis
- 4.3 Bracco Diagnostic
- 4.3.1 Bracco Diagnostic Profiles
- 4.3.2 Bracco Diagnostic Product Information
- 4.3.3 Bracco Diagnostic Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.3.4 Bracco Diagnostic SWOT Analysis
- 4.4 Covidien
- 4.4.1 Covidien Profiles
- 4.4.2 Covidien Product Information
- 4.4.3 Covidien Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.4.4 Covidien SWOT Analysis
- 4.5 GE Healthcare
- 4.5.1 GE Healthcare Profiles
- 4.5.2 GE Healthcare Product Information
- 4.5.3 GE Healthcare Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.5.4 GE Healthcare SWOT Analysis
- 4.6 Eli Lilly
- 4.6.1 Eli Lilly Profiles
- 4.6.2 Eli Lilly Product Information
- 4.6.3 Eli Lilly Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.6.4 Eli Lilly SWOT Analysis
- 4.7 Alseres Pharmaceuticals
- 4.7.1 Alseres Pharmaceuticals Profiles
- 4.7.2 Alseres Pharmaceuticals Product Information
- 4.7.3 Alseres Pharmaceuticals Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.7.4 Alseres Pharmaceuticals SWOT Analysis
- 4.8 Aposense
- 4.8.1 Aposense Profiles
- 4.8.2 Aposense Product Information
- 4.8.3 Aposense Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.8.4 Aposense SWOT Analysis
- 4.9 Yangtze River Pharmaceutical
- 4.9.1 Yangtze River Pharmaceutical Profiles
- 4.9.2 Yangtze River Pharmaceutical Product Information
- 4.9.3 Yangtze River Pharmaceutical Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.9.4 Yangtze River Pharmaceutical SWOT Analysis
- 4.10 Jiangsu Hengrui Medicine
- 4.10.1 Jiangsu Hengrui Medicine Profiles
- 4.10.2 Jiangsu Hengrui Medicine Product Information
- 4.10.3 Jiangsu Hengrui Medicine Contrast Media/Contrast AgentsSales, Sales Value (Million USD), Price and Gross Profit
- 4.10.4 Jiangsu Hengrui Medicine SWOT Analysis
- 4.11 Shanghai Xudong Haipu Pharmaceutical
5 Market Performance for Manufacturers
- 5.1 Global Contrast Media/Contrast Agents Sales (K Units) and Market Share by Manufacturers 2014-2020
- 5.2 Global Contrast Media/Contrast Agents Revenue (M USD) and Market Share by Manufacturers 2014-2020
- 5.3 Global Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 5.4 Global Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 5.5 Market Concentration
6 Regions Market Performance for Manufacturers
- 6.1 China Market Performance for Manufacturers
- 6.1.1 China Contrast Media/Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
- 6.1.2 China Contrast Media/Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.1.3 China Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 6.1.4 China Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 6.1.5 Market Concentration
- 6.2 USA Market Performance for Manufacturers
- 6.2.1 USA Contrast Media/Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
- 6.2.2 USA Contrast Media/Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.2.3 USA Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 6.2.4 USA Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 6.2.5 Market Concentration
- 6.3 Europe Market Performance for Manufacturers
- 6.3.1 Europe Contrast Media/Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
- 6.3.2 Europe Contrast Media/Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.3.3 Europe Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 6.3.4 Europe Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 6.3.5 Market Concentration
- 6.4 Japan Market Performance for Manufacturers
- 6.4.1 Japan Contrast Media/Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
- 6.4.2 Japan Contrast Media/Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.4.3 Japan Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 6.4.4 Japan Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 6.4.5 Market Concentration
- 6.5 Korea Market Performance for Manufacturers
- 6.5.1 Korea Contrast Media/Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
- 6.5.2 Korea Contrast Media/Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.5.3 Korea Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 6.5.4 Korea Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 6.5.5 Market Concentration
- 6.6 India Market Performance for Manufacturers
- 6.6.1 India Contrast Media/Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
- 6.6.2 India Contrast Media/Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.6.3 India Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 6.6.4 India Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 6.6.5 Market Concentration
- 6.7 Southeast Asia Market Performance for Manufacturers
- 6.7.1 Southeast Asia Contrast Media/Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
- 6.7.2 Southeast Asia Contrast Media/Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.7.3 Southeast Asia Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 6.7.4 Southeast Asia Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 6.7.5 Market Concentration
- 6.8 South America Market Performance for Manufacturers
- 6.8.1 South America Contrast Media/Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
- 6.8.2 South America Contrast Media/Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.8.3 South America Contrast Media/Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
- 6.8.4 South America Contrast Media/Contrast Agents Gross Margin of Manufacturers 2014-2020
- 6.8.5 Market Concentration
7 Global Contrast Media/Contrast Agents Market Assessment by Regions (2014-2020)
- 7.1 Global Contrast Media/Contrast Agents Sales (K Units) and Market Share by Regions 2014-2020
- 7.2 Global Contrast Media/Contrast Agents Revenue (M USD) and Market Share by Regions 2014-2020
- 7.3 Global Contrast Media/Contrast Agents Price (USD/Unit) by Regions 2014-2020
- 7.4 Global Contrast Media/Contrast Agents Gross Margin by Regions 2014-2020
8 Development Trend for Regions
- 8.1 Global Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.2 China Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.3 USA Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.4 Europe Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.5 Japan Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.6 Korea Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.7 India Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.8 Southeast Asia Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.8 Southeast Asia Contrast Media/Contrast Agents Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
- 9.1 Upstream Source
- 9.2 Technology
- 9.3 Cost
10 Channel Analysis
- 10.1 Market Channel
- 10.2 Manufacturing Plants Distribution
11 Consumer Analysis
- 11.1 Cardiology Industry
- 11.2 Oncology Industry
- 11.3 Neurology Industry
- 11.4 Others Industry
12 Market Forecast 2021-2026
- 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
- 12.1.1 Global Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
- 12.1.2 Global Contrast Media/Contrast Agents Sales (K Units) and Growth Rate 2021-2026
- 12.1.3 China Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.4 USA Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.5 Europe Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.6 Japan Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.7 Korea Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.8 India Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.9 Southeast Asia Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.10 South America Contrast Media/Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
- 12.2.1 Overall Market Performance
- 12.2.2 Iodinated
- 12.2.3 Gadolinium-Based
- 12.2.4 Barium-Based
- 12.3 Sales (K Units) Forecast by Application 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 Cardiology
- 12.3.3 Oncology
- 12.3.4 Neurology
- 12.3.5 Others
- 12.4 Price (USD/Unit) and Gross Profit
- 12.4.1 Global Contrast Media/Contrast Agents Price (USD/Unit) Trend 2021-2026
- 12.4.2 Global Contrast Media/Contrast Agents Gross Profit Trend 2021-2026
13 Conclusion
According to XYZResearch study, over the next five years the Contrast Media/Contrast Agentsmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Contrast Media/Contrast Agentsbusiness.
Contrast Media/Contrast Agents market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
Global markets continue to sink as the coronavirus spreads, reaching over 200 countries in total by the end of March. Now the outbreak continued to grow, as the number of cases in USA, Italy, Spain, Germany, France all spiked, Europe and USA have now become the epicenter of the outbreak, Cases in China appear have steadied in April, but there’s growing concern about the overall impact to the global market.
In China market, which experienced a difficult 2019 due to slowing domestic consumption and the impact of the Sino-US trade war, is once again facing more disruption and uncertainty at the hands of the coronavirus pandemic. Sales and consumption all fell in the first quarter of 2020, compared with the same period in 2019. The sales revenue of the major players will likely continue slowing in the 2nd quarter but in the second half of the year the fiscal and monetary policy would likely cause a strong rebound
In order to stop the spread of the COVID-19 outbreak, countries and world capital have been put under strict lockdown, bringing a total halt to major industrial production chains. It has caused supply chain disruptions for nearly three-quarters of U.S. companies, and in the second quarter, domestically consumption is likely to be hit even harder. The same situation also appeared in Europe, as the epidemic has required large-scale restrictions on the movement of people, investment, consumption and exports will all be strongly impacted by the epidemic, domestic production and consumption will plummet in the first half of 2020. We expected a U-shaped recovery in the second half of the year in USA and Europe market.
Brazil is already the hardest hit country in South America, many of these nations are still in the early stages of the virus’s proliferation. Infection levels have not yet peaked in April. South America 's market were on shaky ground even before the devastating impacts of the coronavirus, following a synchronized economic slowdown last year. China’s market downturn is impacting its trading partners in this region.
China, Japan, South Korea, India, and other Asia countries took the lead in introducing unprecedented measures to contain the virus, the market confidence in Asia-Pacific region is returning, EU and USA have relaxed its fiscal rules with maximum flexibility, this will stimulate the market demand in the second half of 2020.
Due to delays in the transport of components and raw materials, along with quarantine restrictions, the transportation of raw materials is affected, this will cause tight supply, and then the price of raw materials to rise. Meanwhile, as end-user demand weakens, many players are also facing the risk of higher inventory backlog, which may lead to passive production reduction, some traditional retailers began to develop the online business.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Contrast Media/Contrast Agents for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Contrast Media/Contrast Agents market competition by top manufacturers/players, with Contrast Media/Contrast Agents sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Guerbet Group
Bayer Healthcare
Bracco Diagnostic
Covidien
GE Healthcare
Eli Lilly
Alseres Pharmaceuticals
Aposense
Yangtze River Pharmaceutical
Jiangsu Hengrui Medicine
Shanghai Xudong Haipu Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Iodinated
Gadolinium-Based
Barium-Based
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Contrast Media/Contrast Agents for each application, including
Cardiology
Oncology
Neurology
Others
If you have any special requirements, please let us know and we will offer you the report as you want.